(FRT) Federal Realty Investment - Overview
Stock: Retail Centers, Mixed Use, Residential Units, Reuse Projects
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.57% |
| Yield on Cost 5y | 6.01% |
| Yield CAGR 5y | 0.98% |
| Payout Consistency | 98.6% |
| Payout Ratio | 2.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 16.9% |
| Relative Tail Risk | -2.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.07 |
| Alpha | -11.65 |
| Character TTM | |
|---|---|
| Beta | 0.713 |
| Beta Downside | 0.653 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.38% |
| CAGR/Max DD | 0.11 |
Description: FRT Federal Realty Investment January 06, 2026
Federal Realty Investment Trust (NYSE:FRT) is a leading owner, operator, and redeveloper of high-quality, retail-focused properties concentrated in major coastal markets and select underserved regions with strong economic and demographic fundamentals. Founded in 1962, the REIT’s portfolio comprises 103 open-air shopping centers and mixed-use destinations-including Santana Row, Pike & Rose, and Assembly Row-totaling roughly 27.9 million sq ft of commercial space, about 3,600 tenants, and 3,000 residential units. The company emphasizes long-term, sustainable growth by targeting markets where retail demand outpaces supply, and it boasts a record 58-year streak of quarterly dividend increases, the longest in the REIT industry.
Key operating metrics as of the latest quarter show an occupancy rate near 96% and a same-store sales growth of roughly 3% YoY, reflecting resilience despite broader e-commerce pressures. The REIT’s earnings are sensitive to interest-rate movements, with a weighted-average cost of debt around 4.2%, while demographic trends-particularly rising household incomes and population growth in coastal metros-continue to underpin foot-traffic and rent growth. A sector-wide driver is the shift toward experiential retail and mixed-use concepts, which Federal Realty has capitalized on through its lifestyle-oriented assets.
For a deeper, data-driven analysis of FRT’s valuation and scenario modeling, explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 346.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.35 > 1.0 |
| NWC/Revenue: 0.37% < 20% (prev -1.23%; Δ 1.60% < -1%) |
| CFO/TA 0.07 > 3% & CFO 597.1m > Net Income 346.9m |
| Net Debt (4.70b) to EBITDA (893.9m): 5.26 < 3 |
| Current Ratio: 1.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (86.0m) vs 12m ago 2.36% < -2% |
| Gross Margin: 67.31% > 18% (prev 0.67%; Δ 6663 % > 0.5%) |
| Asset Turnover: 14.47% > 50% (prev 13.95%; Δ 0.52% > 0%) |
| Interest Coverage Ratio: 3.03 > 6 (EBITDA TTM 893.9m / Interest Expense TTM 177.1m) |
Altman Z'' -0.29
| A: 0.00 (Total Current Assets 360.3m - Total Current Liabilities 355.6m) / Total Assets 8.86b |
| B: -0.14 (Retained Earnings -1.25b / Total Assets 8.86b) |
| C: 0.06 (EBIT TTM 536.3m / Avg Total Assets 8.67b) |
| D: -0.23 (Book Value of Equity -1.25b / Total Liabilities 5.40b) |
| Altman-Z'' Score: -0.29 = B |
Beneish M -2.94
| DSRI: 1.09 (Receivables 249.0m/215.7m, Revenue 1.25b/1.18b) |
| GMI: 1.00 (GM 67.31% / 67.40%) |
| AQI: 1.00 (AQ_t 0.95 / AQ_t-1 0.95) |
| SGI: 1.06 (Revenue 1.25b / 1.18b) |
| TATA: -0.03 (NI 346.9m - CFO 597.1m) / TA 8.86b) |
| Beneish M-Score: -2.94 (Cap -4..+1) = A |
What is the price of FRT shares?
Over the past week, the price has changed by +4.55%, over one month by +4.80%, over three months by +11.56% and over the past year by -0.04%.
Is FRT a buy, sell or hold?
- StrongBuy: 6
- Buy: 5
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FRT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 112.3 | 6.2% |
| Analysts Target Price | 112.3 | 6.2% |
| ValueRay Target Price | 110.6 | 4.6% |
FRT Fundamental Data Overview February 03, 2026
P/E Forward = 31.25
P/S = 6.9832
P/B = 2.8408
P/EG = 3.6481
Revenue TTM = 1.25b USD
EBIT TTM = 536.3m USD
EBITDA TTM = 893.9m USD
Long Term Debt = 4.72b USD (from longTermDebt, last quarter)
Short Term Debt = 244.1m USD (from shortTermDebt, last quarter)
Debt = 4.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.70b USD (from netDebt column, last quarter)
Enterprise Value = 13.48b USD (8.78b + Debt 4.81b - CCE 111.3m)
Interest Coverage Ratio = 3.03 (Ebit TTM 536.3m / Interest Expense TTM 177.1m)
EV/FCF = 25.30x (Enterprise Value 13.48b / FCF TTM 532.8m)
FCF Yield = 3.95% (FCF TTM 532.8m / Enterprise Value 13.48b)
FCF Margin = 42.45% (FCF TTM 532.8m / Revenue TTM 1.25b)
Net Margin = 27.64% (Net Income TTM 346.9m / Revenue TTM 1.25b)
Gross Margin = 67.31% ((Revenue TTM 1.25b - Cost of Revenue TTM 410.3m) / Revenue TTM)
Gross Margin QoQ = 67.27% (prev 68.45%)
Tobins Q-Ratio = 1.52 (Enterprise Value 13.48b / Total Assets 8.86b)
Interest Expense / Debt = 0.97% (Interest Expense 46.8m / Debt 4.81b)
Taxrate = 21.0% (US default 21%)
NOPAT = 423.7m (EBIT 536.3m * (1 - 21.00%))
Current Ratio = 1.01 (Total Current Assets 360.3m / Total Current Liabilities 355.6m)
Debt / Equity = 1.50 (Debt 4.81b / totalStockholderEquity, last quarter 3.21b)
Debt / EBITDA = 5.26 (Net Debt 4.70b / EBITDA 893.9m)
Debt / FCF = 8.82 (Net Debt 4.70b / FCF TTM 532.8m)
Total Stockholder Equity = 3.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.00% (Net Income 346.9m / Total Assets 8.86b)
RoE = 10.82% (Net Income TTM 346.9m / Total Stockholder Equity 3.21b)
RoCE = 6.76% (EBIT 536.3m / Capital Employed (Equity 3.21b + L.T.Debt 4.72b))
RoIC = 5.58% (NOPAT 423.7m / Invested Capital 7.60b)
WACC = 5.79% (E(8.78b)/V(13.59b) * Re(8.54%) + D(4.81b)/V(13.59b) * Rd(0.97%) * (1-Tc(0.21)))
Discount Rate = 8.54% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.64%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈443.9m ; Y1≈547.6m ; Y5≈932.6m
Fair Price DCF = 260.3 (EV 27.16b - Net Debt 4.70b = Equity 22.46b / Shares 86.3m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -48.95 | EPS CAGR: -45.79% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.45 | Revenue CAGR: 6.59% | SUE: 4.0 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.76 | Chg30d=+0.008 | Revisions Net=+0 | Analysts=4
EPS next Year (2026-12-31): EPS=3.16 | Chg30d=+0.001 | Revisions Net=-4 | Growth EPS=-10.0% | Growth Revenue=+6.0%